FIGURE
Fig 6
- ID
- ZDB-FIG-191230-640
- Publication
- Prill et al., 2019 - Myomesin is part of an integrity pathway that responds to sarcomere damage and disease
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig 6
Embryos treated with tricaine to inhibit movement and contraction of skeletal sarcomeres from 18 to 32 hpf showed myomesin incorporates normally in untreated (A) and treated (B) wild-type siblings. Myomesin incorporation is absent in tricaine treated |
Expression Data
Antibody: | |
---|---|
Fish: | |
Condition: | |
Anatomical Terms: | |
Stage: | Prim-15 |
Expression Detail
Antibody Labeling
Phenotype Data
Fish: | |
---|---|
Condition: | |
Observed In: | |
Stage: | Prim-15 |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ PLoS One